Opinion
Video
Analyzing Treatment-Refractory Patients
Panelists discuss how managing bronchiectasis exacerbations involves targeted antibiotics based on sputum cultures, augmenting mucus clearance with devices, and considering surgical intervention when medical management fails.
Clinical Brief: Approaches to Bronchiectasis Management Beyond Bronchodilators
Main Discussion Topics
- Bronchodilators have a limited role in bronchiectasis management compared with chronic obstructive pulmonary disease and asthma.
- Infection is the primary trigger for exacerbations, making antibiotics a mainstay of treatment.
- Augmented mucus clearance is a crucial complementary approach.
Key Points for Physicians
- Regular sputum cultures help determine appropriate antibiotic choices.
- Combine nebulized hypertonic saline with bronchodilators (albuterol/levalbuterol preferred over anticholinergics).
- Anticholinergics may thicken mucus, potentially making expectoration more difficult.
- Consider airway clearance devices (high-frequency chest wall oscillation, intrapulmonary percussive ventilation) when medical therapies are insufficient.
- Surgical intervention should be considered when infections cannot be controlled medically.
Notable Insights
Patients may be unable to tolerate long-term antibiotics for conditions like MAI complex, making surgery an important consideration in treatment algorithms.
Clinical Significance
A comprehensive approach to bronchiectasis management should prioritize infection control and enhance mucus clearance, with bronchodilators playing a supporting rather than central role.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
